LMIM
GSK icon

Lockheed Martin Investment Management’s GSK GSK Stock Holding History

Lockheed Martin Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-115,120
Closed -$6.21M – 139
2017
Q2 		$6.21M Hold
115,120
– – 0.34% 48
2017
Q1 		$6.07M Buy
+115,120
New +$5.84M 0.35% 42

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Lockheed Martin Investment Management's GSK Position: Q3 2017 in Review

Lockheed Martin Investment Management sold out of GSK (GSK) in Q3 2017, closing a stake of 115,120 shares — an estimated $6.21M sold.

Lockheed Martin Investment Management first reported a position in GSK in Q1 2017 and held it in 2 quarters. The position peaked at $6.21M in Q2 2017. 741 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Lockheed Martin Investment Management reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 115,120 GSK shares in Q3 2017, an estimated $6.21M.
  • Lockheed Martin Investment Management first reported a position in GSK in Q1 2017 and held it in 2 quarters.
  • Lockheed Martin Investment Management's GSK position peaked at $6.21M in Q2 2017.
  • 741 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Lockheed Martin Investment Management's 13F filing for Q3 2017, filed 6 Nov 2017.